The Aga Khan University (AKU) commemorated World Malaria Day by unveiling the Thatta Malaria Elimination Plan (TMEP), a groundbreaking initiative aimed at eradicating malaria from one of Pakistan’s most affected areas.
Thatta, which reported over 10,000 cases in 2023, holds the highest malaria burden in the country. Malaria remains a prominent global health issue, with 247 million cases and 619,000 fatalities worldwide. In the South-East Asia region, Pakistan significantly contributes to the disease’s transmission, with 95% of its population at risk. The health system faces tremendous strain, impacting social and economic development nationwide.
Prof. M. Asim Beg, Principal Investigator and TMEP Project Lead, emphasized the complexity of the issue, describing it as a multidimensional challenge influenced by socioeconomic vulnerabilities, post-flood repercussions, limited healthcare access, and favorable climatic conditions for disease proliferation.
The launch also featured the introduction of the Malaria Elimination Consortium, established by AKU in 2023 to bolster the national elimination strategy. The TMEP aims to transform Thatta into a malaria-free zone, creating a replicable model for eradication that could be expanded across Sindh, Pakistan, and globally.
AKU spearheads the Plan in collaboration with the Government of Pakistan, the Government of Sindh, and the Directorate of Malaria Control, alongside international partners like GLIDE, Zenysis Technologies, and Universidade NOVA de Lisboa. These partners contribute financial resources, technological expertise, and global insights to the project.
The TMEP is enhancing cooperation among national, provincial, and district-level stakeholders, paving the way for future expansion nationwide. Sindh’s Minister for Health, Dr Azra Pechuho, lauded the initiative, highlighting its potential to uplift communities across Sindh.
The Plan also incorporates findings from the EFFORT clinical trial, introducing new treatment methods for malaria. Dr Salim Virani, Vice Provost Research at AKU, pointed out the trial’s innovative approach, conducted under real-world conditions in Karachi and Thatta. The trial revealed two new treatments significantly reduced recurrence rates, with Tafenoquine showing particular promise.
The TMEP aligns with the World Malaria Day theme “Malaria Ends With Us: Reinvest, Reimagine, Reignite,” and aims to enhance the health system’s capacity for malaria diagnosis, treatment, and surveillance. It also seeks to foster community involvement in prevention and control, leading to lasting behavioral change at the grassroots level.